Objective To evaluate role of serum estradiol levels in predicting likelihood of pregnancy in women undergoing GnRH-a protocol in IVF-ET cycles. Design A 3-year retrospective analysis of estradiol levels on down-regulated day 2, day 6, and day of hCG trigger and subsequent clinical pregnancy rates. Setting A university hospital tertiary referral centre. Population or Sample Women undergoing IVF treatment. Methods Hormonal assessment on the down-regulated day 2, day 6, and day of hCG trigger. Main Outcome Measure(s) Comparison of hormonal profile, antral follicular count on day 2, endometrial thickness on day of trigger, and number of oocytes retrieved between pregnant and the non-pregnant group. The prediction of IVF success was based on the quantitative levels of estradiol on a specific day in down-regulated cycle. Result(s) The overall pregnancy rate was 32.25 % (50/ 160). Estradiol level on down-regulated day 2 was 31.9 ± 12.6 and on the day of trigger was 1,996.46 ± 1,252.36 in pregnant women, which was significantly higher as compared to estradiol levels in nonpregnant women (27.6 ± 12.3 and 1,525
Introduction
Infertility affects millions of couples worldwide. Childlessness is a life crisis and impaired fertility has been reported to affect 10-15 % of couples [1] .
According to the 2009 Assisted Reproductive Technology Report of CDC on ART success rate, clinical pregnancy was 36.9 % [2]. The success of IVF is age dependent; it's success is 47.4 % for women under the age of 35 years, 38.7 % for women ages 35-37 years, 30.1 % for women ages 38-40 years, 20.3 % for women ages 41-42 years, and 10.7 % in women ages 43-44 years.
The prime concern in in vitro fertilization (IVF) cycle is to obtain sufficient number of mature oocytes, good quality embryos, and finally achieve a successful pregnancy. The high cost and relatively low implantation rates in IVF have given rise to the need to evaluate the predictors of success in these women. Prediction of successful IVF outcome has focused on clinical research for many years. Previous reports suggest the role of various parameters like levels of hormones [follicular stimulating hormone (FSH), estradiol, inhibin A, and inhibin B], number of ovarian antral follicles, anti-mullerian hormone, and the influence of woman's age in predicting successful pregnancy in IVF cycles [3, 4, [5] [6] [7] [8] [9] [10] . However, no consensus exists till date [11, 12] .
The role of estradiol (E 2 ) in IVF cycles is well known up to the fertilization stage, however its role beyond that stage remains controversial. On the day of hCG trigger (d-hCG), due to increased number of follicles, high estradiol levels lead to low endometrial receptivity and thus decreased pregnancy rates in IVF cycles [12, 13] . Different cutoffs of serum estradiol levels have been observed on day 4-6 and on the day of hCG trigger during the stimulation cycle by some researchers [14] .
Based on the aforesaid facts, the aim of our study was to assess the role of serum estradiol levels on down-regulated day 2 of menstrual cycle, day 6 of ovarian stimulation, and day of hCG trigger in predicting the pregnancy rate in women undergoing controlled ovarian hyperstimulation in IVF-ET cycles.
Materials and Methods
Using a computerized database, record of 186 women for IVF-ET carried out from March 2008 to August 2011, at the IVF and Reproductive Biology Centre, Department of Obstetrics and Gynecology, Maulana Azad Medical College and associated Lok Nayak Hospital New Delhi, was studied. The exclusion criteria comprised any relevant systemic disease or endocrinal disorder, severe endometriosis or uterine and ovarian anomalies, no more than three previous failed IVF, no previous IVF cycle with a poor ovarian response or ovarian hyperstimulation syndrome. A total of 160 patients who successfully completed the IVF-ET procedure were recruited. Seventeen women who failed to respond to ovarian stimulation and nine women who had ovarian hyperstimulation syndrome were excluded from the study. Due to the retrospective study design based on routine practice, consultation with the hospital ethics committee was not required.
Informed written consent was obtained from all couples visiting our centre, followed by detailed history with general, physical, and gynecological evaluation along with all standard investigations for infertility. The male partner was also evaluated including semen analysis (based on WHO criteria, 1999) [13] . A total of 3-5 mL of venous blood was drawn from the antecubital vein from all women on the second day of their spontaneous menstrual cycle for estimation of serum FSH, luteinizing hormone (LH), E 2 , thyroid stimulating hormone, and progesterone (P 4 ) levels. Patients were started on ''conventional long protocol'' in the same cycle by GnRH analog (Leuprolide acetate, Leupride, Sun Pharmaceutical Ind. Ltd, 0.5 mg intramuscularly daily). Down regulation was confirmed by day 2 baseline ovarian and endometrial assessment on transvaginal sonography (TVS) with serum FSH, LH, E 2 , and P 4 estimation. Ovarian stimulation was done with daily injection of dosages ranging from 225 IU of recombinant gonadotropin (Recombinant-human follicle stimulating hormone, Folligraf, Bharat Serums and Vaccines Ltd, India). TVS was done on day 6 of ovarian stimulation to assess follicular growth and endometrial thickness along with serum E 2 and P 4 levels. According to individuals' response, the doses of gonadotropins were adjusted for next 5 or 6 days. Serum E 2 and P 4 were repeated once three or more follicles were 16-18 mm on TVS.
Human chorionic gonadotropin (hCG, Inj. Fertigyn, Sun Pharmaceutical Ind. Ltd.) 10,000 IU was administered intramuscularly to simulate luteinizing hormone surge and to achieve final follicular maturation. Transvaginal oocyte retrieval was carried out under general anesthesia, 34-36 h after hCG administration. Grading of embryos was done on day 3 before embryo transfer. Luteal phase was supported by vaginal micronized progesterone (Tab Susten, Sun Pharmaceutical Ind. Ltd.) 600 mg daily, in two divided doses, starting immediately after the oocytes retrieval. Urine pregnancy test and serum b-hCG estimation were done 16 days after the embryo transfer to confirm pregnancy. The presence of fetal cardiac activity on TVS, two weeks post serum b-hCG estimation confirmed clinical pregnancy.
Statistical Analysis
Group A (pregnant group) and Group B (non-pregnant group) were compared with the help of SPSS 13.0 (Chicago, IL, USA) statistical software package. The descriptive statistics was represented as mean ± SD.
The groups were analyzed by using Independent Student t-test/Mann Whitney test wherever applicable, to compare the mean of estradiol levels in both the groups.
The change in the estradiol levels on day 2, day 6, day of hCG trigger, and successful IVF outcome was studied by applying repeated measure analysis followed by post receiver operating characteristic (ROC) comparison by Bonferroni method. ROC curve of the model was constructed and the area under curve was used for the assessment and effectiveness of the parameter to predict likelihood of the pregnancy. The significance was observed with p \ 0.05.
Results
A total of 160 women consecutively underwent IVF-ET cycles from March 2008 to August 2011. The clinical pregnancy rate in this group was 31.25 % per embryo transfer. Of the total 160 women, 50 (50/160, 31.25 %) patients had a viable intrauterine pregnancy (group A), while 110 (110/160, 68.75 %) women failed to conceive (group B) after IVF-ET treatment. Table 1 shows the comparison of different parameters between Group A and Group B. No significant difference was found in terms of mean age (in years) in women with viable pregnancies (32.28 ± 3.79, range 24-40 years, p = 0.42) as compared to the women in non-pregnant group (31.73 ± 4.62, range 20-43 years). However the mean infertility duration (in years) of the pregnant women (6.50 ± 3.66, range 01-18 years, p = 0.42) was slightly less as compared to the non-pregnant group of women (7.02 ± 4.33, range 09-13 years), but was found to be non-significant.
Basal serum FSH and LH levels showed no significant difference between the two groups. The level of serum FSH in group A was 5.13 ± 2.8 (range 1.1-6.8 mIU/mL) and in group B was 5.63 ± 6.9 (range 1.4-7.9 mIU/mL) p = 0.51. The level of serum LH in group A was 3.54 ± 3.2 (range 0.3-15.6 mIU/mL) and in group B was 3.36 ± 5.05 (range 0.1-12.3 mIU/mL) p = 0.17. The antral follicular count (AFC) was also non-significant in group A (7.40 ± 3.9 ranging 01-20 in both the ovaries) versus group B (7.75 ± 4.1 ranging 01-23 in both the ovaries). No significant differences in the number of days of stimulation, endometrial thickness, number of oocytes retrieved, and number of embryos replaced to the uterine cavity in both the groups (Table 1) .
Independent Student t-test was performed to analyze the mean difference in the levels of estradiol at down-regulated day 2, day 6, and day of hCG trigger during ovarian stimulation between the group A and group B women who underwent IVF-ET cycle. There was a clear mean difference in the down-regulated day 2 (Table 2) estradiol levels between group A (ranged from 5.8-49.7 pg/mL, mean 31.9 ± 12.6) and group B (ranged from 4.51-49.30 pg/mL, mean 27.5 ± 12.3). Estradiol levels are found to be higher in group A (Fig. 1) . This comparison was found to be statistically significant (p = 0.043).
Similarly, there was a mean difference in the serum estradiol levels on the day of hCG trigger between group A (ranged from 429.73-6,510.0 pg/mL, mean 1,996.4 ± 1,252.3) and group B (ranged from 67.0-7,185.0 pg/mL, mean 1,525.3 ± 1,116.4). The levels were found to be significantly higher in pregnant group (p = 0.025).
As far as day 6 estradiol levels were considered, between group A (ranged from 41.5-1,076.0 pg/mL mean 408.6 ± 292.5) and group B (ranged from 19.50-1,001.0 pg/ mL, mean 354.5 ± 276.2), the mean difference was statistically non-significant (p = 0.273).
Antral follicular count on day 2 (p = 0.598), endometrial thickness on day of trigger (p = 0.683), and number of oocytes retrieved (p = 0.623) were non-significantly allied with the success of IVF.
To justify the results derived from student t-test and forecasting the pregnancy outcome in IVF-ET cycle based on estradiol levels, the change of the estradiol levels on day 2, day of hCG trigger, and successful IVF outcome were a All values are expressed in mean ± SD. p \ 0.05 is significant studied by applying repeated measure analysis followed by post ROC comparison by Bonferroni method. ROC curve of the model was constructed and the area under curve was used for the assessment and effectiveness of the parameter to predict the likelihood of pregnancy. We observed that with an estradiol level C31.2 pg/mL on day 2 of downregulated cycle, 61.8 % women can achieve pregnancy with p = 0.040 (area under curve 60.7 % and sensitivity 62.0 %; Fig. 2 ) and when estradiol levels are C1,400 pg/ mL on the day of trigger, 59 % women can achieve pregnancy with p = 0.007 (area under curve 63.4 % and sensitivity 60.0 %; Fig. 3 ).
Discussion and Conclusion
Achievement of a successful pregnancy is the mainstay of an IVF program. The pregnancy rates in IVF-ET treatment are nearly 30-35 % [2]. Early identification of factors which can predict the IVF outcome is, therefore, of great value. For a long time, clinical research has been focused on the evaluation of predictors like FSH [3] , estradiol [4] , inhibin A [5] , inhibin B [6] , age [7] , and antral follicles count [8] . Pregnancy success in IVF-ET cycle depends on endometrial receptivity [14] , which is related to embryo quality and implantation ability. It is well established that certain level of estradiol per follicle is required to obtain pregnancy [15] . We thus attempted to explore the efficacy of E 2 levels as a marker for clinical pregnancy. Serum estradiol was used to monitor controlled ovarian hyperstimulation. Both low (500 pg/mL) and high ([4,000 pg/mL) serum estradiol concentrations, on the day of hCG administration, resulted in undesirably low and high oocyte yields, respectively, and thus, diminished their probabilities to achieve pregnancy. Elevated or diminished levels of estradiol could produce impaired maturation of oocyte cytoplasm and decrease the probability of obtaining pregnancy [16] .
Optimal level of estradiol on down-regulated day 2 and day of hCG trigger is more likely to obtain a good number of oocytes and better embryos than with inferior levels of estradiol. Thus, the early appearance of estrogen within the follicle allows the follicle to respond to relatively low concentrations of FSH. The dominance of estradiol and FSH in follicular fluid is essential for sustained accumulation in granulosa cells, continued follicular growth, and estradiol production [17] . The present study suggested that mean estradiol levels at down-regulated day 2 of menstruation C31.2 pg/mL and day of hCG trigger C1,400 pg/mL are associated with a higher pregnancy rate (61.8 and 59.0 % respectively). Mean difference of E 2 levels at day 6 showed no statistical significance between groups A (pregnant group) and group B (non-pregnant group).
The role of patient's age in predicting performance in ART is well established. Thus, fecundity in natural and stimulated cycles declines with maternal age. Ovarian reserve diminishes with age and as a result the spontaneous fecundity rate also declines which in turn has an impact on the IVF outcome. Older women have less number of oocytes and thus lower implantation rates. But its predictive value is limited if considered as an isolated factor [18] .
Antral follicular count on day 2 (p = 0.598), endometrial thickness on day of trigger (p = 0.683), and number of oocytes retrieved (p = 0.628) were non-significantly allied with the success of IVF in our study.
Anifandis et al. [15] suggested that the success of pregnancies in IVF-ET cycles was maximum when peak estradiol levels at the time of hCG administration are between 1,001 and 2,000 pg/mL; this is a significant prognostic marker. In our study, the range was found to be between 900 and 1,900 pg/mL.
According to Theocharis et al. [16] , controlled ovarian stimulation for IVF cycles is usually monitored by serum estradiol levels. In our study, number of oocytes, total embryos obtained, and number of high grade embryos, were significantly better for patients with estradiol level above 90th percentile at hCG administration for the three age groups: group A (age \ 35 years, E 2 [ 4,233 pg/mL), group B (age 35-38 years, E 2 [ 3,904 pg/mL), and group C (age [ 38 years, E 2 [ 3,897 pg/mL) [19] .
The number of oocytes retrieved ranged from 1-22 oocytes among pregnant women with an average of eight oocytes retrieved. Among the eight oocytes, 80-90 % got fertilized of which 50 % developed normally to ''A'' grade embryos. A total of 1-3 embryos were transferred per cycle.
To obtain pregnancy in an IVF cycle, the need for good quality embryos and the technique of embryo transfer are very crucial. Thus, patients with good embryos but difficult or bad transfer may hamper the probability of achieving pregnancy [20, 21] . Good interaction between the embryos and the endometrium is another crucial factor in order to favor the implantation process [22, 23] . When we estimated the probability of pregnancy in our study, it was not possible to know what happened during embryo transfer or appraisal of interaction between embryo and endometrium. But we assumed the same consequences as the same technique was applied by the same surgeon in all women.
The present study shows that it is possible to predict the probability of achieving pregnancy among patients undergoing IVF program. Estradiol levels on down-regulated day 2 and on the day of hCG trigger had a significant impact on the success of IVF-ET.
These data provide valuable information for better understanding of the correlation between parameters related to IVF cycles, and may help clinicians in counseling patients regarding the cycle response and expected pregnancy rate.
From this study we ascertain that, if the estimated estradiol level is C31.2 pg/mL on down-regulated day 2 cycle, 61.8 % women can achieve pregnancy (p = 0.040). Further assumption is, if estradiol level is C1,400 pg/mL on the day of hCG trigger, 59.0 % women can achieve pregnancy (p = 0.007 statistically significant).
Further studies with larger sample size are needed to confirm this model of prediction for achieving pregnancy in IVF-ET cycles. Fig. 3 ROC curve of estradiol levels on day 2 and day of hCG trigger in Group B (non-pregnant group) forecasting the likelihood of the pregnancy in IVF procedure
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